Dottikon Es Holding AG (DESN) - Total Assets
Based on the latest financial reports, Dottikon Es Holding AG (DESN) holds total assets worth CHF1.41 Billion CHF (≈ $1.78 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Dottikon Es Holding AG - Total Assets Trend (2005–2026)
This chart illustrates how Dottikon Es Holding AG's total assets have evolved over time, based on quarterly financial data. Also see market cap of Dottikon Es Holding AG for the company's overall valuation and market capitalisation.
Dottikon Es Holding AG - Asset Composition Analysis
Current Asset Composition (March 2026)
Dottikon Es Holding AG's total assets of CHF1.41 Billion consist of 36.4% current assets and 63.6% non-current assets. Review Dottikon Es Holding AG total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF0.00 | 8.5% |
| Accounts Receivable | CHF102.21 Million | 7.3% |
| Inventory | CHF208.19 Million | 14.8% |
| Property, Plant & Equipment | CHF0.00 | 0.0% |
| Intangible Assets | CHF2.85 Million | 0.2% |
| Goodwill | CHF0.00 | 0.0% |
Asset Composition Trend (2005–2026)
This chart illustrates how Dottikon Es Holding AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Dottikon Es Holding AG stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dottikon Es Holding AG's current assets represent 36.4% of total assets in 2026, an increase from 31.2% in 2005.
- Cash Position: Cash and equivalents constituted 8.5% of total assets in 2026, up from 3.8% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 9.0% in 2005.
- Asset Diversification: The largest asset category is inventory at 14.8% of total assets.
Dottikon Es Holding AG Competitors by Total Assets
Key competitors of Dottikon Es Holding AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hubei Zhenhua Chemical Co Ltd
SHG:603067
|
China | CN¥5.21 Billion |
|
Kemira Oyj
HE:KEMIRA
|
Finland | €3.13 Billion |
|
Xinfengming Group Co Ltd
SHG:603225
|
China | CN¥67.08 Billion |
|
Shandong Shida Shenghua Chem
SHG:603026
|
China | CN¥12.53 Billion |
|
L&F Co. Ltd
KQ:066970
|
Korea | ₩3.35 Trillion |
|
Tangshan Sunfar Silicon Ind
SHG:603938
|
China | CN¥3.42 Billion |
|
Zhejiang Sanmei Chemical Industry Co Ltd
SHG:603379
|
China | CN¥9.36 Billion |
|
Shaanxi Lighte Optoelectronics Material Co. Ltd. A
SHG:688150
|
China | CN¥2.28 Billion |
Dottikon Es Holding AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.56 | 2.67 | 5.49 |
| Quick Ratio | 2.11 | 1.65 | 4.11 |
| Cash Ratio | 0.00 | 0.78 | 2.50 |
| Working Capital | CHF368.33 Million | CHF315.64 Million | CHF332.05 Million |
Dottikon Es Holding AG - Advanced Valuation Insights
This section examines the relationship between Dottikon Es Holding AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.44 |
| Latest Market Cap to Assets Ratio | 2.62 |
| Asset Growth Rate (YoY) | 4.3% |
| Total Assets | CHF1.41 Billion |
| Market Capitalization | $3.69 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Dottikon Es Holding AG's assets at a significant premium (2.62x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Dottikon Es Holding AG's assets grew by 4.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Dottikon Es Holding AG (2005–2026)
The table below shows the annual total assets of Dottikon Es Holding AG from 2005 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | CHF1.41 Billion ≈ $1.78 Billion |
+4.32% |
| 2025-03-31 | CHF1.35 Billion ≈ $1.71 Billion |
+13.26% |
| 2024-03-31 | CHF1.19 Billion ≈ $1.51 Billion |
+13.10% |
| 2023-03-31 | CHF1.05 Billion ≈ $1.33 Billion |
+22.80% |
| 2022-03-31 | CHF858.41 Million ≈ $1.09 Billion |
+11.95% |
| 2021-03-31 | CHF766.75 Million ≈ $969.39 Million |
+56.53% |
| 2020-03-31 | CHF489.84 Million ≈ $619.29 Million |
+5.78% |
| 2019-03-31 | CHF463.09 Million ≈ $585.47 Million |
+5.64% |
| 2018-03-31 | CHF438.38 Million ≈ $554.23 Million |
+15.21% |
| 2017-03-31 | CHF380.51 Million ≈ $481.07 Million |
+11.54% |
| 2016-03-31 | CHF341.16 Million ≈ $431.32 Million |
+2.77% |
| 2015-03-31 | CHF331.98 Million ≈ $419.71 Million |
+0.27% |
| 2014-03-31 | CHF331.10 Million ≈ $418.60 Million |
-2.62% |
| 2013-03-31 | CHF339.99 Million ≈ $429.84 Million |
-5.16% |
| 2012-03-31 | CHF358.48 Million ≈ $453.21 Million |
-2.27% |
| 2011-03-31 | CHF366.80 Million ≈ $463.73 Million |
-4.24% |
| 2010-03-31 | CHF383.04 Million ≈ $484.27 Million |
+6.01% |
| 2009-03-31 | CHF361.33 Million ≈ $456.82 Million |
+5.05% |
| 2008-03-31 | CHF343.97 Million ≈ $434.87 Million |
+3.59% |
| 2007-03-31 | CHF332.05 Million ≈ $419.81 Million |
+2.57% |
| 2006-03-31 | CHF323.73 Million ≈ $409.28 Million |
+2.41% |
| 2005-03-31 | CHF316.12 Million ≈ $399.66 Million |
-- |
About Dottikon Es Holding AG
Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries. The company's chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl b… Read more